Edition:
India

Hansa Medical AB (HMED.ST)

HMED.ST on Stockholm Stock Exchange

199.70SEK
4:31pm IST
Change (% chg)

-3.90kr (-1.92%)
Prev Close
203.60kr
Open
202.80kr
Day's High
206.20kr
Day's Low
196.80kr
Volume
120,685
Avg. Vol
138,434
52-wk High
290.00kr
52-wk Low
158.00kr

Select another date:

Wed, Apr 25 2018

BRIEF-Hansa Medical Q1 Operating Loss Widens To SEK 46.6 Million

* Q1 OPERATING LOSS SEK 46.6 MILLION VERSUS LOSS SEK 44.8 MILLION YEAR AGO

BRIEF-Hansa Medical Appoints Søren Tulstrup New President And CEO

* SØREN TULSTRUP APPOINTED NEW PRESIDENT AND CEO OF HANSA MEDICAL

BRIEF-Hansa Medical Granted Orphan Drug Designation By FDA

* HANSA MEDICAL RECEIVES FDA ORPHAN DRUG DESIGNATION FOR IDES AND THE TREATMENT OF GUILLAIN-BARRÉ SYNDROME Source text for Eikon: Further company coverage: (Gdynia Newsroom)

BRIEF-Hansa Medical AB Q4 Net Revenue Sek 1.0 ‍​ Million Versus Sek 0.5 Million Year Ago

* Q4 NET REVENUE SEK 1.0 ‍​ MILLION VERSUS SEK 0.5 MILLION YEAR AGO

Select another date: